1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. GENELUX CORP
Genelux Corp
XNAS: GNLX
2.61 0.05 (1.95%)
161.8K
XNAS Volume

XNAS 22 Sep, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Genelux Corp - GNLX - stock price prediction, stock price target, analyst ratings from 6 analysts

Genelux Corp has a share price target of US$ 19, revenue growth forecast of 78400.0%, and profit growth estimate of -15.0% for FY27, based on top 6 analyst calls.